Research and Markets: Community-Acquired Bacterial Pneumonia (Event Driven)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9z2qh7/communityacquired) has announced the addition of Decision Resources, Inc's new report "Community-Acquired Bacterial Pneumonia (Event Driven)" to their offering.

The community-acquired bacterial pneumonia (CABP) market is highly crowded and genericized; nevertheless, it has important unmet needs for new therapies that are active against key drug-resistant pathogens and that can demonstrate efficacy in the moderate to severe CABP population. Although the majority of CABP patients are treated in the outpatient setting, the inpatient setting represents more than half of the CABP market and will be the area of highest commercial growth over the 2010-2020 period. Key drivers of the CABP inpatient segment include the uptake of marketed and emerging antibiotic brands and the anticipated increase in disease severity among hospitalized patients.

Key Topics Covered:

Executive Summary

What are the key parameters of the CABP market?

What factors are driving the market for CABP therapies?

What factors are constraining the market for CABP therapies?

What are the drug development activities of note in CABP?

What do the experts say?

What key challenges and opportunities remain?

1 Etiology and Pathophysiology

2 Epidemiology and Patient Populations

3 Current Therapies and Medical Practice

4 Unmet Needs

5 Emerging Therapies

6 Market Outlook

Appendix

Tables and Figures

For more information visit http://www.researchandmarkets.com/research/9z2qh7/communityacquired

Source: Decision Resources, Inc